# L-DOPA vs. Placebo for Depression and Psychomotor Slowing in Older Adults

> **NCT03761030** · PHASE4 · TERMINATED · sponsor: **New York State Psychiatric Institute** · enrollment: 51 (actual)

## Conditions studied

- Major Depressive Disorder
- Dysthymia
- Depression

## Interventions

- **DRUG:** L-DOPA
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03761030
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-01-09
- **Primary completion:** 2021-09-08
- **Final completion:** 2021-09-08
- **Target enrollment:** 51 (ACTUAL)
- **Why stopped:** The project end date was reached prior to the full sample enrollment
- **Last updated:** 2023-05-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03761030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03761030, "L-DOPA vs. Placebo for Depression and Psychomotor Slowing in Older Adults". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT03761030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*